PDCD1 and neoplasm: While splenocytes from mice treated with anti-PD-1 alone did not show enhanced tumor-specific reactivity compared to mock, we found significantly increased tumor-specific IFN-γ responses after treatment with MV at t1 (Figure 7, top left panel, adj.